IBO

IMPACT BIOMEDICAL INC.

NYSE · Pharmaceutical Preparations

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Impact Biomedical Inc. develops therapeutic and consumer health products, including compounds targeting inflammation, infectious disease, and pain, which it licenses or commercializes through partnerships. The company focuses on early-stage drug and health product candidates derived from its research pipeline rather than marketing an approved pharmaceutical portfolio.

Industry

Pharmaceutical Preparations

Headquarters

Houston, TX

Exchange

NYSE

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
DSS, INC.10% Owner	Sell	$1K	156at $7.06	Sep 24, 2026
DSS, INC.10% Owner	Sell	$398	723at $0.55	Sep 22, 2026
DSS, INC.10% Owner	Sell	$188	27at $6.95	Sep 23, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for IBO.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable IBO activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.